Table.
Demographic Features and Echocardiographic, Biochemical, and Inflammatory Parameters of the Study Groups
| Study Group (n=25) | Control Group (n=20) | P Value | |
|---|---|---|---|
| Sex, female/male | 17/8 | 13/7 | .832 |
| Mean age, y | 51.6±8.2 | 47.9±9.2 | .166 |
| Body mass index, kg/m2 | 35.6±5.5 | 24.3±2.5 | .0001 |
| Waist circumference, cm | 107.4±11.5 | 83.3±8.1 | .0001 |
| Hip circumference, cm | 117.0±12.4 | 94.4±7.0 | .0001 |
| Waist/hip circumference ratio | 0.9±0.09 | 0.9±0.06 | .07 |
| Body fat percentage, % | 39.7±7.4 | 23.5±7.0 | .0001 |
| Total cholesterol, mg/dL | 227.3±33.1 | 183.9±25.2 | .0001 |
| Triglyceride, mg/dL | 229.4±65.6 | 100.9±40.9 | .0001 |
| LDL cholesterol, mg/dL | 135.2±34.1 | 115.9±18.5 | .03 |
| HDL cholesterol, mg/dL | 44.8±8.3 | 59.8±12.1 | .0001 |
| Left ventricular mass index, g/m2 | 91.50±16.78 | 86.44±15.27 | .302 |
| Fasting glucose, mg/dL | 132.0±38.5 | 88.6±8.5 | .0001 |
| HbA1c, % | 6.7±1.7 | 4.8±0.4 | .0001 |
| Urea, mg/dL | 28.7±8.2 | 29.5±6.5 | .701 |
| Creatinine, mg/dL | 0.85±0.11 | 0.80±0.12 | .136 |
| Uric acid, mg/dL | 5.7±1.0 | 4.4±1.2 | .0001 |
| Urinary albumin excretion, mg/L | 36.5±40.6 | 8.9±11.4 | .005 |
| White blood cell count, 103/mm3 | 8.37±1.76 | 6.84±0.90 | .001 |
| ESR, mm/h | 8.2±3.1 | 6.4±2.4 | .037 |
| hs‐CRP, mg/dL | 0.6±0.3 | 0.1±0.1 | .0001 |
| Interleukin 6, pg/mL | 5.8±3.9 | 2.5±1.2 | .001 |
| TNF‐α, pg/mL | 2.2±1.1 | 1.9±0.5 | .207 |
| Fibrinogen, mg/dL | 387.8±95.9 | 306.9±30.2 | .001 |
| Flow‐mediated dilation, % | 6.5±4.3 | 10.7±3.5 | .001 |
Abbreviations: ESR, erythrocyte sedimentation rate; HbA1c, hemoglobin A1c; HDL, high‐density lipoprotein; hs‐CRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein; TNF‐α, tumor necrosis factor α.